Pleomorphic medium-sized T-cell lymphoma following Hodgkin's disease (nodular sclerosis type).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9140313.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a 32-year-old woman who presented with Hodgkin's disease, nodular sclerosis type II, subtype I, which necessitated several treatments over 11 years. The patient then developed pleomorphic, medium-sized T-cell lymphoma, which had a fatal outcome within 13 months. The role of radiotherapy, splenectomy, and chemotherapy in second tumor induction is compared with other sequential T-cell lymphomas. The significance of rare Epstein-Barr virus-infected cells during the T-cell lymphoma extension is discussed.
Medical subject headings
- Hodgkin Disease
- Lymph Nodes
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Neoplasms, Second Primary